Skip to main content

Addressing and Managing Requests to Hasten Death

  • Chapter
  • First Online:
Neuropalliative Care

Abstract

In this chapter we discuss how to respond to and address requests by a patient for a hastened death. The initial response should always be exploration and maximization of palliative care. For persistent requests to hasten death that are rational and not the result of inadequate palliative care, discussion and education about the following options are appropriate: withdrawal/withholding of life-sustaining treatment, palliative sedation, voluntarily stopping eating and drinking (VSED), physician-assisted death (PAD), and voluntary active euthanasia (VAE). This discussion will be colored by the legal status for the latter two options in the jurisdiction in which the conversation is being held. We recommend referral to a palliative medicine specialist if there is any uncertainty about the appropriateness of the intervention, and in all cases where palliative sedation to unconsciousness, VSED, PAD, or VAE are being considered. Neurologic patients may present particular challenges in these circumstances. We use amyotrophic lateral sclerosis (ALS), Parkinson disease, Alzheimer’s disease, Huntington’s disease, stroke, and glioblastoma as model diseases to explore the special circumstances in neurology and how various options for a hastened death may be more or less appropriate depending on the underlying illness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carver AC, et al. End-of-life care: a survey of US neurologists’ attitudes, behavior, and knowledge. Neurology. 1999;53(2):284–93.

    Article  CAS  PubMed  Google Scholar 

  2. Quill TE, Battin MP. Physician-assisted dying: the case for palliative care and patient choice. Baltimore: Johns Hopkins University Press; 2004. xv, 342 p

    Google Scholar 

  3. Quill T, Arnold RM. Evaluating requests for hastened death #156. J Palliat Med. 2008;11(8):1151–2.

    Article  PubMed  Google Scholar 

  4. Ganzini L, Goy ER, Dobscha SK. Why Oregon patients request assisted death: family members’ views. J Gen Intern Med. 2008;23(2):154–7.

    Article  PubMed  Google Scholar 

  5. Meier DE, et al. Characteristics of patients requesting and receiving physician-assisted death. Arch Intern Med. 2003;163(13):1537–42.

    Article  PubMed  Google Scholar 

  6. Tolle SW, et al. Characteristics and proportion of dying Oregonians who personally consider physician-assisted suicide. J Clin Ethics. 2004;15(2):111–8.

    PubMed  Google Scholar 

  7. Wang LH, et al. Death with dignity in Washington patients with amyotrophic lateral sclerosis. Neurology. 2016;87(20):2117–22.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Battin MP, et al. Physician-assisted suicide: toward a comprehensive understanding. Report of the Task Force on Physician-assisted Suicide of the Society for Health and Human Values. Acad Med. 1995;70(7):583–90.

    Google Scholar 

  9. Foley KM, Hendin H. The case against assisted suicide: for the right to end-of-life care. Baltimore: Johns Hopkins University Press; 2002. xii, 371 p

    Google Scholar 

  10. Battin MP, et al. Legal physician-assisted dying in Oregon and the Netherlands: evidence concerning the impact on patients in “vulnerable” groups. J Med Ethics. 2007;33(10):591–7.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Emanuel EJ, et al. Attitudes and practices of euthanasia and physician-assisted suicide in the United States, Canada, and Europe. JAMA. 2016;316(1):79–90.

    Article  CAS  PubMed  Google Scholar 

  12. Quill TE, Kimsma G. End-of-life care in The Netherlands and the United States: a comparison of values, justifications, and practices. Camb Q Healthc Ethics. 1997;6(2):189–204.

    Article  CAS  PubMed  Google Scholar 

  13. Burkle CM, Schipper AM, Wijdicks EF. Brain death and the courts. Neurology. 2011;76(9):837–41.

    Article  PubMed  Google Scholar 

  14. Wijdicks EF, et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911–8.

    Article  PubMed  Google Scholar 

  15. Quill TE, Abernethy AP. Generalist plus specialist palliative care – creating a more sustainable model. N Engl J Med. 2013;368(13):1173–5.

    Article  CAS  PubMed  Google Scholar 

  16. Holloway R. Patients who never leave us. Neurology. 2011;77(15):3.

    Article  Google Scholar 

  17. Russell JA, Williams MA, Drogan O. Sedation for the imminently dying: survey results from the AAN Ethics Section. Neurology. 2010;74(16):1303–9.

    Article  PubMed  Google Scholar 

  18. ten Have H, Welie JV. Palliative sedation versus euthanasia: an ethical assessment. J Pain Symptom Manag. 2014;47(1):123–36.

    Article  Google Scholar 

  19. Pope TM, West A. Legal briefing: voluntarily stopping eating and drinking. J Clin Ethics. 2014;25(1):68–80.

    PubMed  Google Scholar 

  20. Quill TE, Lo B, Brock DW. Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA. 1997;278(23):2099–104.

    Article  CAS  PubMed  Google Scholar 

  21. Ivanovic N, Buche D, Fringer A. Voluntary stopping of eating and drinking at the end of life – a ‘systematic search and review’ giving insight into an option of hastening death in capacitated adults at the end of life. BMC Palliat Care. 2014;13(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bolt EE, et al. Primary care patients hastening death by voluntarily stopping eating and drinking. Ann Fam Med. 2015;13(5):421–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Meier DE, et al. A national survey of physician-assisted suicide and euthanasia in the United States. N Engl J Med. 1998;338(17):1193–201.

    Article  CAS  PubMed  Google Scholar 

  24. Initiative and Referendum Institute. 2017. Cited 8 Feb 2017. Available from: http://www.iandrinstitute.org/index.cfm.

  25. Okie S. Physician-assisted suicide – Oregon and beyond. N Engl J Med. 2005;352(16):1627–30.

    Article  CAS  PubMed  Google Scholar 

  26. Hedberg K, Hopkins D, Kohn M. Five years of legal physician-assisted suicide in Oregon. N Engl J Med. 2003;348(10):961–4.

    Article  PubMed  Google Scholar 

  27. Brody H. Kevorkian and assisted death in the United States. BMJ. 1999;318(7189):953–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. van der Heide A, et al. End-of-life decision-making in six European countries: descriptive study. Lancet. 2003;362(9381):345–50.

    Article  PubMed  Google Scholar 

  29. van der Heide A, et al. End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med. 2007;356(19):1957–65.

    Article  PubMed  Google Scholar 

  30. Rabkin J, et al. Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort. Neurology. 2016;87(13):1320–28.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ganzini L, et al. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide. N Engl J Med. 1998;339(14):967–73.

    Article  CAS  PubMed  Google Scholar 

  32. Veldink JH, et al. Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands. N Engl J Med. 2002;346(21):1638–44.

    Article  PubMed  Google Scholar 

  33. Brookmeyer R, et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002;59(11):1764–7.

    Article  PubMed  Google Scholar 

  34. Roberson ED, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005;65(5):719–25.

    Article  CAS  PubMed  Google Scholar 

  35. de Beaufort ID, van de Vathorst S. Dementia and assisted suicide and euthanasia. J Neurol. 2016;263(7):1463–7.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Henig R.M. The last day of her life. The New York Times Magazine 2015 May 14 2015. Cited 16 October 2016. Available from: http://www.nytimes.com/2015/05/17/magazine/the-last-day-of-her-life.html.

  37. Goodarzi Z, et al. Detecting depression in Parkinson disease: a systematic review and meta-analysis. Neurology. 2016;87(4):426–37.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Buter TC, et al. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017–22.

    Article  CAS  PubMed  Google Scholar 

  39. Aarsland D, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387–92.

    Article  PubMed  Google Scholar 

  40. Peralta E. As planned, right-to-die advocate brittany maynard ends her life. The Two-Way November 3, 2014. Available from: http://www.npr.org/sections/thetwo-way/2014/11/03/361094919/as-planned-right-to-die-advocate-brittany-maynard-ends-her-life.

  41. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842–50.

    Article  CAS  PubMed  Google Scholar 

  42. Woehrer A, Bauchet L, Barnholtz-Sloan JS. Glioblastoma survival: has it improved? Evidence from population-based studies. Curr Opin Neurol. 2014;27(6):666–74.

    PubMed  Google Scholar 

  43. Quill TE, Holloway R. Time-limited trials near the end of life. JAMA. 2011;306(13):1483–4.

    Article  CAS  PubMed  Google Scholar 

  44. Paulsen JS, et al. Depression and stages of Huntington’s disease. J Neuropsychiatry Clin Neurosci. 2005;17(4):496–502.

    Article  PubMed  Google Scholar 

  45. Di Maio L, et al. Onset symptoms in 510 patients with Huntington’s disease. J Med Genet. 1993;30(4):289–92.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Duff K, et al. Psychiatric symptoms in Huntington’s disease before diagnosis: the predict-HD study. Biol Psychiatry. 2007;62(12):1341–6.

    Article  PubMed  Google Scholar 

  47. Kirkwood SC, et al. Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol. 2001;58(2):273–8.

    Article  CAS  PubMed  Google Scholar 

  48. Koennecke HC, et al. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology. 2011;77(10):965–72.

    Article  PubMed  Google Scholar 

  49. Andersen KK, Andersen ZJ, Olsen TS. Predictors of early and late case-fatality in a nationwide Danish study of 26,818 patients with first-ever ischemic stroke. Stroke. 2011;42(10):2806–12.

    Article  PubMed  Google Scholar 

  50. Saver JL, Altman H. Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset. Stroke. 2012;43(6):1537–41.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Quill TE. Doctor, I want to die. Will you help me? JAMA. 1993;270(7):870–3.

    Article  CAS  PubMed  Google Scholar 

  52. Dobscha SK, et al. Oregon physicians’ responses to requests for assisted suicide: a qualitative study. J Palliat Med. 2004;7(3):451–61.

    Article  PubMed  Google Scholar 

  53. Emanuel EJ, et al. The practice of euthanasia and physician-assisted suicide in the United States: adherence to proposed safeguards and effects on physicians. JAMA. 1998;280(6):507–13.

    Article  CAS  PubMed  Google Scholar 

  54. Shanafelt TD, et al. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012;172(18):1377–85.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy E. Quill .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Weisbrod, N., Quill, T.E. (2019). Addressing and Managing Requests to Hasten Death. In: Creutzfeldt, C., Kluger, B., Holloway, R. (eds) Neuropalliative Care. Springer, Cham. https://doi.org/10.1007/978-3-319-93215-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93215-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93214-9

  • Online ISBN: 978-3-319-93215-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics